RainDance Technologies Revenue and Competitors

Boston, MA USA

Location

$164.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RainDance Technologies's estimated annual revenue is currently $2M per year.(i)
  • RainDance Technologies's estimated revenue per employee is $167,917
  • RainDance Technologies's total funding is $164.4M.

Employee Data

  • RainDance Technologies has 12 Employees.(i)
  • RainDance Technologies grew their employee count by 0% last year.

RainDance Technologies's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is RainDance Technologies?

RainDance Technologies, Inc. is a nanotechnology company devoted to developing and commercializing the Professional Laboratory System, a platform for droplet-based microfluidics. The Professional Laboratory System is an integrated fluid handling system that provides precise manipulation of minute amounts of fluids for a variety of industrial and research applications within genomic, drug discovery, industrial enzyme development, and molecular diagnostic markets. At the core of the system's power are assay-specific NanoReactor chips composed of fluid handling modules that encapsulate samples and reactants in individual micron-sized droplets. Founded in 2004 by scientists from Harvard University, the Medical Research Centre in Cambridge, and the ESPCI in Paris, RainDance Technologies designed the Professional Laboratory System to be the chemical equivalent of a personal computer. As a computer manipulates bits of information, the system's NanoReactor technology enables the programmable handling of cells and fluid samples for innovative assay and screening applications. The promise of this technology has attracted an outstanding Scientific Advisory Board, including three Nobel Prize winners (Jean-Marie Lehn, Sir Aaron Klug, and Dr. Richard Roberts) and Sir Gregory Winter.

keywords:N/A

$164.4M

Total Funding

12

Number of Employees

$2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RainDance Technologies News

2022-04-20 - Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2028 ...

Roche; QIAGEN; Bio-rad; Agilent; Bioer; Biosynex; Esco; Analytik Jena; Techne; Fluidigm; RainDance Technologies. Analysis of Cardan Shaft...

2022-04-20 - Opportunities for the Global Digital PCR (dPCR) and Real ...

Roche; QIAGEN; Bio-rad; Agilent; Bioer; Biosynex; Esco; Analytik Jena; Techne; Fluidigm; RainDance Technologies. Analysis of Cardan Shaft...

2022-04-17 - dPCR Market Size, Scope And Forecast | Leading Players ...

Bio-Rad Laboratories, Fluidigm, RainDance Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company, Exiqon, Formulatrix, Promega Corporation,...

2017-01-17 - Bio-Rad acquires RainDance, partners with Illumina for single-cell analysis

The news comes less than a week after the launch of the Illumina Bio-Rad Single-Cell Sequencing Solution, announced during the J.P. Morgan Healthcare Conference. Combined, the two deals strengthen the company’s position in the high buzz fields of single-cell analysis and liquid biopsy. Based in ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M14-12%N/A
#2
$1.2M140%N/A
#3
$3.3M21-9%N/A
#4
$5.2M210%N/A
#5
N/A22-35%N/A